Citius Pharmaceuticals (CTXR) Files $250M Mixed Shelf

Citius Pharmaceuticals (NASDAQ: CTXR) has filed $250,000,000 mixed shelf of:

Common Stock
Preferred Stock
Debt Securities
Warrants
Units and/or
Rights

You May Also Be Interested In

• Citius Oncology adds Jonathan Peri to its board of directors
• Lucid files resale prospectus for preferred stock and common shares
• Cue Biopharma Inc. (CUE) files for 1.51M share offering by selling stockholders